OKYO Pharma Limited
$1.59
▲
1.2%
2026-04-21 08:37:00
okyopharma.com
NCM: OKYO
Explore OKYO Pharma Limited stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$85.27 M
Current Price
$1.59
52W High / Low
$3.35 / $1.11
Stock P/E
—
Book Value
$-0.09
Dividend Yield
—
ROCE
127.79%
ROE
82.36%
Face Value
—
EPS
$-0.11
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
4
Beta
-0.12
Debt / Equity
—
Current Ratio
0.58
Quick Ratio
0.4
Forward P/E
-7.55
Price / Sales
—
Enterprise Value
$54.03 M
EV / EBITDA
-8.64
EV / Revenue
—
Rating
None
Target Price
$8
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Valuation is not stretched on P/E basis.
Cons
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Insmed Incorporated | $143.43 | — | $31.02 B | — | -55.4% | -2.49% | $212.75 / $63.81 | $3.45 |
| 2. | Skye Bioscience, Inc. | $0.78 | — | $26.15 M | — | -289.25% | -1.27% | $5.75 / $0.57 | $0.6 |
| 3. | Pluri Inc. | $3.59 | — | $36.08 M | — | -348.95% | 669.52% | $7.13 / $2.82 | $-1.46 |
| 4. | Madrigal Pharmaceuticals, Inc. | $535 | — | $12.26 B | — | -31.61% | -42.49% | $615 / $265 | $26.39 |
| 5. | GeoVax Labs, Inc. | $1.17 | — | $3.38 M | — | -498.05% | -3.77% | $34.75 / $1.14 | $4.13 |
| 6. | Assembly Biosciences, Inc. | $28.13 | — | $446.22 M | — | -5.8% | -5.1% | $39.7 / $9.68 | $13.04 |
| 7. | Precision BioSciences, Inc. | $7.58 | — | $187.43 M | — | -35.84% | -62.71% | $8.82 / $3.53 | $3.83 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -7.09 M | -15.75 M | -13.19 M | -6.22 M |
| Net Profit | -4.71 M | -16.83 M | -13.27 M | -5.43 M |
| EPS in Rs | -0.09 | -0.32 | -0.25 | -0.1 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 3.68 M | 1.54 M | 5.2 M | 4.3 M |
| Total Liabilities | 9.23 M | 7.42 M | 7.26 M | 1.35 M |
| Equity | -5.55 M | -5.88 M | -2.05 M | 2.95 M |
| Current Assets | 3.68 M | 1.54 M | 5.2 M | 4.3 M |
| Current Liabilities | 9.23 M | 7.42 M | 7.26 M | 1.35 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -1.81 M | -9.49 M | -7.7 M | -5.47 M |
| Investing CF | -0 M | 0 M | -0.01 M | -0 M |
| Financing CF | 2.66 M | 6.21 M | 9.32 M | 2.15 M |
| Free CF | -1.81 M | -9.49 M | -7.7 M | -5.47 M |
| Capex | -0 M | — | -0.01 M | -0 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 72.03% | -26.78% | -144.37% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.